Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:03 2026-10-16 pm EDT
|
5-day change | 1st Jan Change | ||
| 86.60 USD | -1.70% |
|
+1.63% | +1.58% |
| Oct. 16 | Buy the Dip or Falling Knife? |  |
| Oct. 16 | Falling bond yields lift stocks | |
| Market Cap | 49.92B 44.37B 41.13B 37.42B 70.61B 4,737B 71.74B 494B 194B 2,472B 187B 183B 7,881B | P/E 2026 * |
34.8x | P/E 2027 * | 26.1x |
|---|---|---|---|---|---|
| Enterprise Value | 46.29B 41.14B 38.13B 34.7B 65.47B 4,393B 66.52B 458B 180B 2,292B 174B 170B 7,308B | EV / Sales 2026 * |
6.84x | EV / Sales 2027 * | 6.02x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Xetra
| EWL | Delayed | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -1.70% | ||
| 1 week | +1.63% | ||
| Current month | +0.32% | ||
| 1 month | -3.00% | ||
| 3 months | -1.41% | ||
| 6 months | +9.55% | ||
| Current year | +1.58% |
| 1 week | 84.55 |  | 88.41 |
| 1 month | 82.42 | | 89.66 |
| Current year | 74.66 | | 96.29 |
| 1 year | 74.43 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.70% | +1.63% | +19.20% | +21.51% | 49.92B | |
| -0.93% | +4.86% | +28.54% | +41.24% | 255B | |
| -1.06% | +4.20% | +8.59% | +8.83% | 161B | |
| -0.27% | +0.65% | -1.82% | +55.64% | 151B | |
| +0.57% | +3.88% | -54.60% | -11.40% | 64.33B | |
| +1.47% | +5.90% | -12.94% | -13.05% | 51.9B | |
| -0.85% | +4.81% | +6.02% | +46.42% | 50.25B | |
| -1.47% | +1.42% | +22.59% | +55.13% | 48.77B | |
| -1.62% | +0.73% | +30.48% | +71.24% | 42.93B | |
| -2.01% | -5.62% | +173.74% | +99.83% | 39.64B | |
| Average | -0.79% | +3.41% | +21.98% | +37.54% | 91.46B | |
| Weighted average by Cap. | -0.75% | +4.01% | +16.14% | +35.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.01B 5.57B 5.07B 9.57B 642B 9.72B 66.97B 26.26B 335B 25.38B 24.84B 1,068B | 7.43B 6.61B 6.12B 5.57B 10.52B 706B 10.68B 73.62B 28.86B 368B 27.9B 27.31B 1,174B |
| Net income | 1.44B 1.28B 1.18B 1.08B 2.03B 136B 2.06B 14.21B 5.57B 71.08B 5.39B 5.27B 227B | 1.9B 1.69B 1.56B 1.42B 2.68B 180B 2.73B 18.79B 7.37B 93.99B 7.12B 6.97B 300B |
| Net Debt | -3.63B -3.23B -2.99B -2.72B -5.14B -345B -5.22B -35.96B -14.1B -180B -13.63B -13.34B -573B | -5.19B -4.62B -4.28B -3.89B -7.35B -493B -7.47B -51.44B -20.17B -257B -19.5B -19.08B -820B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | $86.60 | -1.70% | 4,007,492 |
| 26-10-15 | $88.10 | +1.91% | 4,681,095 |
| 26-10-14 | $86.45 | +1.38% | 4,036,660 |
| 26-10-13 | $85.27 | -1.30% | 3,643,041 |
| 26-10-12 | $86.39 | +1.38% | 3,324,390 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
